Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial
Open Access
- 6 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Biomarker Research
- Vol. 9 (1), 1-10
- https://doi.org/10.1186/s40364-021-00322-8
Abstract
Extracellular vesicles are membrane vesicles that are released into the extracellular environment and accumulate in the circulation in vascular disease. We aimed to quantify circulating extracellular vesicles in pregnant women with type 1 diabetes and to examine associations between extracellular vesicle levels, continuous glucose measures, and pregnancy outcomes. We used plasma samples from the Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial study and quantified circulating extracellular vesicles by flow cytometry (n = 163). Relationships with clinical variables were assessed by repeated measures correlation. Logistic regression was used to assess associations between elevated extracellular vesicle levels and pregnancy outcomes. Platelet extracellular vesicle levels were inversely associated with glucose time above range and glycaemic variability measures (P < 0.05). A weak positive association was observed between endothelial extracellular vesicles and mean amplitude of glycemic excursion (P < 0.05). In a univariate logistic regression model, high baseline endothelial extracellular vesicles was associated with increased risk of neonatal intensive care unit (NICU) admission (OR: 2.06, 1.03–4.10), and respiratory distress requiring ventilation (OR: 4.98, 1.04–23.92). After adjusting for HbA1c and blood pressure the relationship for NICU admission persisted and an association with hyperbilirubinemia was seen (OR: 2.56, 1.10–5.94). Elevated platelet extracellular vesicles were associated with an increased risk of NICU admission (OR: 2.18, 1.04–4.57), and hyperbilirubinemia (OR: 2.61, 1.11–6.12) after adjusting for HbA1c and blood pressure. High levels of extracellular vesicles in early pregnancy were associated with adverse neonatal outcomes. Assessment of extracellular vesicles may represent a novel approach to personalized care in type 1 diabetes pregnancy.Keywords
Funding Information
- Institute of Circulatory and Respiratory Health (PJT-153224)
This publication has 45 references indexed in Scilit:
- Extracellular vesicles: structure, function, and potential clinical uses in renal diseasesBrazilian Journal of Medical and Biological Research, 2013
- Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticlesSurgery for Obesity and Related Diseases, 2013
- Microparticles Induce Cell Cycle Arrest Through Redox‐Sensitive Processes in Endothelial Cells: Implications in Vascular SenescenceJournal of the American Heart Association, 2012
- Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid RaftsArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomesEuropean Heart Journal, 2010
- Circulating Endothelial Microparticles in Diabetes MellitusMediators of Inflammation, 2010
- The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 DiabetesDiabetes Care, 2009
- Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cellsMicrovascular Research, 2008
- Circulating Microparticles in Normal Pregnancy and Pre-EclampsiaPlacenta, 2008
- Endothelium-derived microparticles impair endothelial function in vitroAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004